nohealthproblemsnews.com
Home »
(Reuters Health) – Despite adjustments to the U.S. Preventive Services Task Force lung cancer screening criteria, disparities in eligibility between […] The US Food and Drug Administration (FDA) has granted an accelerated approval to mobocertinib (Exkivity, Takeda) for the treatment of […] BRUSSELS (Reuters) – The European Commission said on Thursday it was suing Slovakia for years-long breaches of legal limits on […] A novel drug that offers multilineage protection from chemotherapy-induced myelosuppression has been approved by the US Food and Drug Administration. […]
Revised Guidelines Did Not Reduce Disparities in Lung Cancer Screening Eligibility
FDA Approves First Oral Drug for NSCLC With EGFR Exon20 Insertion
EU Sues More Countries Over Air Pollution, Nature and Water
First Drug That Protects Against Chemo-Induced Myelosuppression
